We aimed at finding a simple rule to determine the shortest duration of dual therapy for all HCV genotypes , obtained by multiplying time to Initial Viral Response , IVR ( first undetectable HCV-RNA ) by 4 ( Tailored Therapy-4 , or TT4 ) .